chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient received PCV 20 vaccine to L deltoid on 11/21/22.  Since then, has been developing redness, swelling, burning sensation, and warmth to injection site x 1 hour after injection.  Denies fever, chills, numbness, tingling, weakness.
A report was received from a health professional on 17Oct02, concerning a 2 year old male vaccinee who was inadvertently administered 0.5ml Fluvirin on 15Oct02. On 15Oct02, the vaccinee experienced an overdose after inadvertently receiving 0.5ml Fluvirin. No adverse effects were reported at time of report. No other information was available. There was insufficient information to determine the reporter's causality assessment.
Received HPV shot at 11:55 am on 8-30-12 - left office went to lunch - nausea after lunch - vomited at school at 2:10 pm - fainted (out for 1 1/2 - 2 minutes) Now has headache and heartburn. Rechecked at 3:30 in office. No treatment.
Fever 100.9, body aches, severe chest pains, headache, & chills - events are currently ongoing
redness at vaccine site (left arm only) well demarcated area of erythema about 4 inches in diameter, hot to touch. Tylenol q 4-6 hours x 24 hours. Return to clinic prn.
pt recv vax 27MAR96 & 20JUN96 pt devel a vesicular rash involving the dorsal surface of lt upper arm;rash was subsequently dx by dermatologist as herpes zoster;specimens were taken for PCR analysis of varicella virus;
Pt given pneumo vaccine to left deltoid on 12-7-10. Pt came into office on 12-9-10 c/o pain, swelling to injection site, also with fever and cold sweats.
Patient developed a 6 inch circle on right arm where vaccine administered. Later became warm to touch. Patient was prescribed Cephalexin for possible infection. Otherwise patient unharmed.
Change in menstrual cycle. Did not get period after vaccination for 4 months. My cycle was normal and regular prior to vaccinations. Once menstrual cycle returned in July it was very short and abnormal. I have had 2 periods since July and it is now December. My inter-cycle intervals ranging from 2-3 months. Now almost 9 months since my vaccination the unexplained menstrual cycle abnormalities do not make sense. Talked to my OBGYN about my symptoms and she stated this has happened in many patients and she had no real answer as to why the prolonged side effects. It makes sense having abnormalities due to immune response for the first few weeks but not for it to persist like this.
Severe headache and body aches beginning 20 hours after vaccine, lasting 3 hours.
It felt pretty similar to Strep Throat - had white patches on my tonsils but I did not have a sore throat. I kind of ignored them. I had them for about a week and then one day I woke up was feeling pain while swallowing and I developed a little bit of a cough. I did go to Urgent Care - that first week of just seeing the white patches and that was two Fridays ago (two weeks ago) in person - the doctor just recommended salt water gargling and tea. Three days after that visit, I looked in the mirror and I looked at my throat and it had spread to both of my tonsils (the white patches)-  and the next morning I woke up and felt like my throat was going to close and it was painful swallowing. I called the Dr  -(free video visit). He did not recommend I get a COVID test. I had Azithromycin for the symptoms. I completed course about six days  later  - last Friday.
No adverse event; A patient received a dose of PNEUMOVAX 23 that was recalled; A patient received a dose of PNEUMOVAX 23 that was recalled; This spontaneous report was received from a medical assistant concerning a patient of unknown age and gender. The patient's concurrent conditions, medical history, drug reactions, allergies and concomitant medications were not reported.  On 13-OCT-2020, the patient was vaccinated with a dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (lot # S036495, expiration date reported and validated as 13-SEP-2021), at a dose of 0.5 milliliters (mL) as prophylaxis (route and site of administration were not reported) that was recalled (incorrect product storage, recalled product administered). No adverse events were reported.  combinationproductreport: Yes; brandname: PNEUMOVAX23 SYRINGE (DEVICE); commondevicename: Pneumococcal Vaccine, Polyvalent (23-valent); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: S036495; expirationdate: 13-SEP-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability
Patient developed an outbreak of shingles 2 days after receiving the vaccine, on her lower left quadrant. Patient states that this outbreak is worse pain/Sx-worse compared to her 2 previous episodes, just in blister stage at this point.
11/3/2021, I was coughing, like a mild flu, a little aching. I took a COVID-19 test on 11/5/2021 and it came back positive. On 11/6/2021, I talked to my doctor, and I received the Monoclonal Antibodies on 11/10/2021 which helped. COVID-19 lasted a little over a week.
Guillain-Barre syndrome following vaccination per neurology Difficulty keeping his balance, marked weakness in dorsiflexion of his feet bilaterally, and elevated protein in his cerebrospinal fluid occurred approximately 3 weeks post vaccination.
Fever 102-103, rash on face - dry cheeks. Vomited once resolved in 24 hour without further fever, rash on new symptoms.
Body Aches-24 hours Chills-24 hours Headache-4 days (improved daily) Fatigue-4 days (improved daily) *I do have Juvederm Ultra Plus XC fillers (injected in February and October 2020) in my lips and did NOT have any swelling from either dose*
Parent brought patient back to the clinic due to (L) leg swelling, injection site being hot and painful. Rash, no fever. Dxd with (L) leg cellulitis and was prescribed CEFDINIR powder for reconstitution 75mg/ml 9.75 ml PO q8hrs x 10days.
RINGING IN THE EAR THAT HAS WORSENED THE NEXT DAY
put her down; This case was reported by a consumer via call center representative and described the occurrence of tiredness in a 80-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included surgery (had her 2nd breast cancer surgery 5 weeks before receiving Shingrix), lymph node dissection (was a breast cancer survivor and has had her lymph nodes removed) and breast cancer (Breast cancer survivour).   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, unknown after receiving Shingrix, the patient experienced tiredness. On an unknown date, the outcome of the tiredness was unknown.   It was unknown if the reporter considered the tiredness to be related to Shingrix.  Additional details were provided as follows: The patient was a friend of the reporter.  The age at vaccination was not reported. The patient stated that the shot put her down for a day or two.
Patient experienced swelling around his cheeks about 1 hour after receiving the vaccine. He didn't report any trouble breathing/ shortness of breath. Advised to go to the nearest emergency room to get it checked out by a doctor.
Headache & Myalgia Narrative:  OTC Tylenol every 6 hours as needed  Other Relevant History:
Within 1 hour of the vaccination, the soreness in my left arm was traveling to my neck and back. By evening I was having whole body aches, headache, neck pain, and fatigue. This persisted into the next day - causing me to miss work.
Received phone call from patient  on 11/13/23 regarding vaccine adverse reactions that started on 10/30/23. Patient stated receiving the 2nd dose of  Shingles vaccine that day in the morning. She had a history of Asthma. It wasn't until later that evening that she experienced severe difficulty breathing and joint pain. None of her inhalers were improving her symptoms. Patient called EMS and was transported to the hospital.  Patient was hospitalized on 11/4/23 through 11/7/23 for Acute Respiratory Failure.  Patient did not have these reactions after the first Shingles vaccine. She stated that she had a headache and was not feeling well for 2 to 3 days. Symptoms improved after first Shingles vaccine.
Axonal-variant Guillaine-Barre Syndrome hospitizalition to ICU with paralysis on 4/1/2022, treated with plasmaphersis 8 times, at hospital, and then transferred to Clinic for diagnosis; and continued treatment of IVIGB; still hospitalized; currently in ICU receiving care and rehabilitation, not an end date applicable at this time;
Lethargic; Tired; temperarure high as 102.8F and 102.9F and Sunday as high as 102.4F and 102.6F; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of LETHARGY (Lethargic), FATIGUE (Tired) and PYREXIA (temperarure high as 102.8F and 102.9F and Sunday as high as 102.4F and 102.6F) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced LETHARGY (Lethargic), FATIGUE (Tired) and PYREXIA (temperarure high as 102.8F and 102.9F and Sunday as high as 102.4F and 102.6F). At the time of the report, LETHARGY (Lethargic), FATIGUE (Tired) and PYREXIA (temperarure high as 102.8F and 102.9F and Sunday as high as 102.4F and 102.6F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In January 2021, Body temperature: 102.8f and 102.9f (High) 102.8F and 102.9F. On 21-Jan-2021, Body temperature: 102.4f and 102.6f (High) high as 102.4F and 102.6F..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       On unknown date, Lab tests included COVID, flu, pneumonia, and UTI - all returned negative. No Concomitant medications were provided Treatment medication included an IV in the hospital
This spontaneous report was received from a pharmacist referring to multiple unspecified patients of unknown age and gender. The patient's pertinent medical history, concurrent conditions, concomitant medications and drug reactions/allergies were not reported. On unknown dates, the patients were vaccinated with the improperly stored doses of ZOSTAVAX (dose, frequency, route, lot # and expiration date were not reported) reconstituted with properly stored sterile diluent(manufacturer unknown) (dose, frequency, route, lot # and expiration date were not reported) for prophylaxis(Incorrect product storage). There were no adverse effects reported. The temperature excursion, time frame, previous temperature excursion were unknown. There were no data logger was involved. This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1707USA001111:
Soreness 3/24/11. Redness/swelling/warmth 3/25/11 AM. At time of visit with me (3/25/11 at 2:15pm, about 48h after vaccine given), local inflammatory reaction at (R) upper outer arm measures 9.5 cm vertical x 6.25 cm horizontal.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unknown age and gender. No information was provided regarding concomitant medications, concurrent conditions or medical history. On or about 07-AUG-2015, the patient was inoculated with ZOSTAVAX by a physician as recommended for routine adult health maintenance for the prevention of shingles (lot#, expiration date, dose and route were not provided). The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain condition of herpes zoster. On or about 28-OCT-2016, the patient was treated by a physician for a blistering vesicular outbreak which was diagnosed as herpes zoster or shingles. The patient continued to suffer ongoing injuries with mental and physical pain and suffering. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. The causality assessment of events was reported to be related.
Left arm pain itching, redness and swelling approx. 6cm/3cm.
I got the vaccine on 08/22/2021 and my arm turned red and hot. It stayed like that for about 48 hours. Then it went away. About a week later my arm turned red and swollen again. I did a telehealth visit on 08/30/2021 and they prescribed doxycycline 100 mg twice a day, Benadryl, and cold compresses. My arm is still red and irritated.
A red bump about 2 inches long and 1 inch wide. Hot to the touch. Its been over two weeks and I still have a bruise
Fever. Chills. Fainting.  Nauseated. whole body aches.dizziness. 11:30 pm to 5am  on the 27th to 28th.  Broke fever 5am . Lethargic and dizzy continued today. Painful gums on left side.
Headache, Myalgia & NauseaVomiting Narrative: facial swelling, nausea, headache, fever and hot flashes,arm soreness and muscle ahes.
8 minutes after second dose - felt dizzy, tingling in left arm, numb tongue, more intense dizziness. Felt the need to lay down . BP extremely elevated diastolic above 100. Heart rate elevated . With in 5 -10 minutes vitals stabilized,  NP reports I had panic attack.  (However, I've heard of other people having similar reactions, they all went to follow up in ER, or  primary care and all their cardiac labs and  other tests were WNL.)  Through out the day I experienced heart palpitations, fast heart beat, and some chest pressure.  3 days post vaccine I experienced some dizziness when walking through target. Afterwards I had some chest pain.  the feeling of Heaviness on my chest . Took tums helped a little then the feeling came back. Went for a 2 mile walk helped a little then came back. Watched tv,,  chest pressure was still there .   By one week post vaccine I felt completely normal, no chest pain, no dizziness, no heart palpitations. I did not seek care with a primary care or other providers because I assumed this was a strong immune response elicited by the second dose of the Covid vaccine. However, I was encouraged to report these symptoms
she could barely get up; nauseas with a very upset stomach; even my eyes were sore; weak; injection site was warm to touch; slight dizziness; low-grade fever 98.8; nauseas with a very upset stomach; she was achy/very sore/muscles are sore; has a headache; the injection site was warm to touch, sore; having no energy exhausted; chills; This spontaneous case was reported by a consumer and describes the occurrence of DYSSTASIA (she could barely get up), ABDOMINAL DISCOMFORT (nauseas with a very upset stomach), EYE PAIN (even my eyes were sore), ASTHENIA (weak) and VACCINATION SITE WARMTH (injection site was warm to touch) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 058H21A, 006B21A and 042B21-2A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Dec-2021, the patient experienced DYSSTASIA (she could barely get up), ABDOMINAL DISCOMFORT (nauseas with a very upset stomach), EYE PAIN (even my eyes were sore), ASTHENIA (weak), VACCINATION SITE WARMTH (injection site was warm to touch), DIZZINESS (slight dizziness), PYREXIA (low-grade fever 98.8), NAUSEA (nauseas with a very upset stomach), MYALGIA (she was achy/very sore/muscles are sore), HEADACHE (has a headache), VACCINATION SITE PAIN (the injection site was warm to touch, sore), FATIGUE (having no energy exhausted) and CHILLS (chills). The patient was treated with ACETYLSALICYLIC ACID (BAYER ASPIRIN) for Adverse event, at an unspecified dose and frequency. At the time of the report, DYSSTASIA (she could barely get up), ABDOMINAL DISCOMFORT (nauseas with a very upset stomach), EYE PAIN (even my eyes were sore), ASTHENIA (weak), VACCINATION SITE WARMTH (injection site was warm to touch), DIZZINESS (slight dizziness), PYREXIA (low-grade fever 98.8), NAUSEA (nauseas with a very upset stomach), MYALGIA (she was achy/very sore/muscles are sore), HEADACHE (has a headache), VACCINATION SITE PAIN (the injection site was warm to touch, sore), FATIGUE (having no energy exhausted) and CHILLS (chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Dec-2021, Body temperature: 98.8 (High) Low grade fever- 98.8.         No relevant concomitant medications were reported. Lot number of Booster dose is 058HXA most likely 058H21A.
26 y/o female presented with dizziness at approximately 1401 s/p receiving first dose of pfizer vaccine, VS: SpO2: 99% on Room Air, Pulse: 109, BP: 92/62.  Patient denied any medical history. Allergies include Amoxicillin & Children's Advil. Medication's include Birth Control. Case was placed on floor with legs elevated. Repeated vital signs with case laying on floor @ 1414 SpO2: 93% on Room Air, Pulse: 99, BP: 110/72; patient reported improved symptoms and denied any other symptoms. Patient was raised to seated position and she was given a water bottle and chips. Patient then stood at 1424 and reported resolution of dizziness and denied any other symptoms. Standing VS @1424: SpO2: 95% on Room Air, Pulse: 115, BP: 119/85. Patient ambulated approximately 40ft with a steady gait. Denied any further symptoms. Encouraged patient to rest for the rest of day and lay down if she does experience any dizziness later on today, verbalized understanding and agreed. Also encouraged patient to talk to PCP regarding elevated pulse; verbalized understanding and agreed.
Systemic itching after booster vaccination; This spontaneous case was reported by a non-health professional and describes the occurrence of PRURITUS (Systemic itching after booster vaccination) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.  On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRURITUS (Systemic itching after booster vaccination). At the time of the report, PRURITUS (Systemic itching after booster vaccination) outcome was unknown.     Concomitant product use was not provided by the reporter.  The patient experienced systemic itching after booster vaccination. The booster recipient was taking medication on a regular basis for treatment at the time of report.
Pt. Returned 2 days after with baseball size Allergic Reaction to INj complained of Itching/Redness/Swelling At Site, PT was seen same day at Doctor given lorAtidine, ZANtAC, Advised to plAce ice oN site
318 patients received dose from vials beyond 30-day use by date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (318 patients received dose from vials beyond 30-day use by date) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (318 patients received dose from vials beyond 30-day use by date). On 11-Jun-2021, EXPIRED PRODUCT ADMINISTERED (318 patients received dose from vials beyond 30-day use by date) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information were provided by the reporter. No treatment information were provided. Refrigeration date were reported as 07-May-2021.
Extremely dry mouth, unsteady on my feet (muscle weakness, shooting pain in both arms).
Patient developed presumptive Guillain-Barré syndrome after receiving the J&J vaccine outside of a hospital.
patient who was16 years of age; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (patient who was16 years of age) in a 16-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (patient who was16 years of age). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (patient who was16 years of age) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
pain at injection site, fatigue on the 23rd. Extreme fatigue on the 24th. Only mild pain at injection site on 25th. No other reactions
Information has been received from a pharmacist concerning a female registered nurse who vaccinated a patient with a dose of ZOSTAVAX (Oka/Merck) contracted shingles.  It was reported that this was not the first time this nurse administered ZOSTAVAX (Oka/Merck) to a patient.  The nurse did received unspecified medical attention.  The has not yet recovered.  No product quality complaint.  Additional information has been requested.
shingles; Information has been received from a lawyer regarding a case in litigation concerning a female patient(pt) of unknown age. The pt's medical history, concurrent conditions and concomitant medications were not provided. On or about 02-NOV-2016, the pt was vaccinated with zoster vaccine live(ZOSTAVAX) (dose, route of administration, anatomical location, lot#, expiration date were unknown) by a pharmacist at a pharmacy for the long-term prevention of shingles and/or zoster-related conditions. Subsequent to pt's zoster vaccine live(ZOSTAVAX) inoculation, pt was treated by a physician for shingles. As a direct and proximate result of zoster vaccine live(ZOSTAVAX), pt has and will continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future.
Pain at site, chills, fever, fatigue beginning 20 hours after injection and lasting for an additional 24 hours after commencement of event.